ADVERTISEMENT
Search

 

Press Releases

 

25

Jan

2024

FDA adds boxed warning to denosumab specific for patients with advanced CKD

Author: Anonym

FDA added a boxed warning to the osteoporosis drug denosumab (Prolia). The agency’s review of the drug indicated risks that warrant new prescribing information. For patients with chronic kidney disease (CKD)—especially those on dialysis or those with a concomitant diagnosis of mineral and bone disorder—FDA said they could develop severe hypocalcemia, or very low levels of calcium in the blood.

Comments (0)
Number of views (3523)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

18

Jan

2024

CDC releases detailed adult immunization schedule for 2024, with revisions

Author: Anonym

CDC’s adult immunization schedule for 2024, which was published in the Annals of Internal Medicine on January 12, 2024, includes updates for several vaccines, including those for respiratory syncytial virus (RSV), meningitis, mpox, and COVID-19. The immunization schedule is based on the recommendations of CDC’s ACIP.

Comments (0)
Number of views (5173)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

12

Jan

2024

Early tecovirimat treatment for mpox disease may benefit people with HIV

Author: Anonym

Early intervention with tecovirimat may stop an mpox infection from advancing to the stages of severe disease in people living with HIV (PWH), new research suggests.

Comments (0)
Number of views (8536)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

11

Jan

2024

Research looks at Paxlovid for long COVID risk

Author: Anonym

Paxlovid did not reduce the risk of developing long COVID in vaccinated, nonhospitalized adults, according to new data published in the Journal of Medical Virology.

Comments (0)
Number of views (4603)
Article rating: 4.0
Read more

Categories: APhA News

Tags: APhA News

8

Jan

2024

Labeling will change for two cholesterol-lowering medications

Author: Anonym

Effective immediately, FDA has changed the labels on two medications used to bring down LDL cholesterol levels: bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet).

Comments (0)
Number of views (3934)
Article rating: 5.0
Read more

Categories: APhA News

Tags: APhA News

RSS
First7891012141516Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT